We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Breakthrough Device That Detects DNA with 100-Fold Greater Sensitivity to Speed Disease Detection

By LabMedica International staff writers
Posted on 05 Oct 2023

Traditional DNA detection methods are like searching for a needle in a haystack, given that there are many other molecules in a sample that are not the target DNA and can interfere with the result. More...

Now, a new method for DNA detection offers 100-fold greater sensitivity than traditional methods, paving the way for faster disease detection at the point of care.

In the new DNA detection method developed by researchers at the University of Massachusetts Amherst (Amherst, MA, USA), the test sample is placed within an alternating electric field, allowing the DNA strands to "dance." Each strand moves with its own unique frequency of oscillation. Researchers can then examine the sample to find a molecule that moves just like the DNA they're looking for, making it easy to identify even when present in extremely low concentrations.

The implications for this groundbreaking method are enormous, particularly for early diagnosis of diseases. Because of its high sensitivity, the test can identify diseases much sooner in their progression, which can be critical for treatment. Moreover, the electric-based method yields results in minutes rather than days, weeks, or months, making it ideal for point-of-care settings. Additionally, the technology is highly portable, resembling the size of a blood sugar monitoring device, which has the potential to make a substantial impact on global health.

“Everyone wants to detect the DNA at a low concentration with a high sensitivity. And we just developed this method to improve the sensitivity by about 100 times with no cost,” said Jinglei Ping, lead author of the paper that appeared in Proceedings of the National Academy of Sciences. “The nano-mechanoelectrical approach can be also integrated with other bioengineering technologies, like CRISPR, to elucidate nucleic acid signaling pathways, comprehend disease mechanisms, identify novel drug targets and create personalized treatment strategies, including microRNA-targeted therapies.”

Related Links:
UMass Amherst


Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Manual Pipetting Aid
Pipette Controllers macro
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The approach supports myocardial infarction diagnosis in resource-limited settings by reducing delays between clinical suspicion and biochemical confirmation (Image Credit: Adobe Stock)

Portable Troponin Assay Brings Heart Attack Diagnosis Closer to Patients

Timely confirmation of myocardial infarction often depends on laboratory testing that may not be immediately available at the point of care. This gap between clinical suspicion and definitive evidence... Read more

Immunology

view channel
Image: Graphical Abstract (Morgane Fournier et al., Cell (2026). DOI: 10.1016/j.cell.2026.04.013)

Study Reveals Immune Mechanism Driving Severe COVID-19 Progression

Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.